10:15 AM EST - Oncolytics Biotech Inc. : Today stated that the previously announced abstract for a poster to be presented at the 2020 Gastrointestinal Cancers Symposium sponsored by ASCO in San Francisco, has been published. The abstract highlights new biomarker data from the randomized study NCI 8601: Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer. Oncolytics Biotech Inc.
shares T.ONC are trading down 7 cents at $3.48.
